MedPath

Comparison of two methods of delivery in women with severe pre eclampsia at term

Phase 4
Conditions
Health Condition 1: O141- Severe pre-eclampsia
Registration Number
CTRI/2021/04/032534
Lead Sponsor
Principal Midnapore Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Diagnosis of severe pre-eclampsia in singleton pregnancy at equal or more than 37 weeks of gestation

Exclusion Criteria

1.Diagnosis of hypertension of systolic blood pressure < 160 mm of Hg and diastolic blood pressure <110 mm Hg with medication

2.Women in labour ( cervical dilatation < 4 cm )

3.Multiple pregnancy , Intrauterine fetal death

4.Any contraindication to vaginal delivery or induction of labour such as Cephalopelvic dis proportion , malpresentation, post cesarean pregnancy ,placenta previa Fetal macrosomia , Fetal distress , IUGR

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome measure will be a composite endpoint of maternal mortality, maternal complications (eclampsia, HELLP syndrome, pulmonary oedema, thromboembolic disease) <br/ ><br>Primary neonatal outcome will be Apgar score of 3 or below, admission to the neonatal intensive care unit (NICU) or neonatal death <br/ ><br>Timepoint: at baseline
Secondary Outcome Measures
NameTimeMethod
Secondary neonatal outcomes will be newborn sepsis, confirmed seizures, necrotizing enterocolitis, hypoxic-ischemic encephalopathy, cardiopulmonary resuscitation or ventilator support within 24 hours after birth,Timepoint: At baseline
© Copyright 2025. All Rights Reserved by MedPath